146 related articles for article (PubMed ID: 28581410)
41. Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.
Hui Z; Zhang X; Starkschall G; Li Y; Mohan R; Komaki R; Cox JD; Chang JY
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1385-95. PubMed ID: 18486357
[TBL] [Abstract][Full Text] [Related]
42. Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
Binkley MS; Hiniker SM; Chaudhuri A; Maxim PG; Diehn M; Loo BW; Shultz DB
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):808-15. PubMed ID: 26831903
[TBL] [Abstract][Full Text] [Related]
43. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study.
Bosmans G; van Baardwijk A; Dekker A; Ollers M; Boersma L; Minken A; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):748-53. PubMed ID: 17011450
[TBL] [Abstract][Full Text] [Related]
44. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
45. Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study.
van Baardwijk A; Bosmans G; Boersma L; Wanders S; Dekker A; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1394-401. PubMed ID: 18258380
[TBL] [Abstract][Full Text] [Related]
46. Cone-beam CT-guided radiotherapy in the management of lung cancer: Diagnostic and therapeutic value.
Elsayad K; Kriz J; Reinartz G; Scobioala S; Ernst I; Haverkamp U; Eich HT
Strahlenther Onkol; 2016 Feb; 192(2):83-91. PubMed ID: 26630946
[TBL] [Abstract][Full Text] [Related]
47. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
48. Investigating the potential impact of four-dimensional computed tomography (4DCT) on toxicity, outcomes and dose escalation for radical lung cancer radiotherapy.
Cole AJ; O'Hare JM; McMahon SJ; McGarry CK; Butterworth KT; McAleese J; Jain S; Hounsell AR; Prise KM; Hanna GG; O'Sullivan JM
Clin Oncol (R Coll Radiol); 2014 Mar; 26(3):142-50. PubMed ID: 24332210
[TBL] [Abstract][Full Text] [Related]
49. Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?
Everitt S; Schneider-Kolsky M; Yuen K; Budd R; Mac Manus M
J Med Imaging Radiat Oncol; 2008 Apr; 52(2):168-77. PubMed ID: 18373810
[TBL] [Abstract][Full Text] [Related]
50. Radiation therapy planning for early-stage Hodgkin lymphoma: experience of the International Lymphoma Radiation Oncology Group.
Maraldo MV; Dabaja BS; Filippi AR; Illidge T; Tsang R; Ricardi U; Petersen PM; Schut DA; Garcia J; Headley J; Parent A; Guibord B; Ragona R; Specht L
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):144-52. PubMed ID: 25670544
[TBL] [Abstract][Full Text] [Related]
51. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
[TBL] [Abstract][Full Text] [Related]
53. Quantifying the impact of immediate reconstruction in postmastectomy radiation: a large, dose-volume histogram-based analysis.
Ohri N; Cordeiro PG; Keam J; Ballangrud A; Shi W; Zhang Z; Nerbun CT; Woch KM; Stein NF; Zhou Y; McCormick B; Powell SN; Ho AY
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e153-9. PubMed ID: 22560544
[TBL] [Abstract][Full Text] [Related]
54. Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography.
Paul J; Yang C; Wu H; Tai A; Dalah E; Zheng C; Johnstone C; Kong FM; Gore E; Li XA
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):463-472. PubMed ID: 28463166
[TBL] [Abstract][Full Text] [Related]
55. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy.
Kwint M; Uyterlinde W; Nijkamp J; Chen C; de Bois J; Sonke JJ; van den Heuvel M; Knegjens J; van Herk M; Belderbos J
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e223-8. PubMed ID: 22560551
[TBL] [Abstract][Full Text] [Related]
56. Use of 4-dimensional computed tomography-based ventilation imaging to correlate lung dose and function with clinical outcomes.
Vinogradskiy Y; Castillo R; Castillo E; Tucker SL; Liao Z; Guerrero T; Martel MK
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):366-71. PubMed ID: 23474113
[TBL] [Abstract][Full Text] [Related]
57. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy.
Deek MP; Nagarajan S; Kim S; Ahmed I; Paul S; Scher ED; Listo M; Chen A; Aisner J; Hussain S; Haffty BG; Jabbour SK
Acta Oncol; 2016 Aug; 55(8):1029-35. PubMed ID: 27219912
[TBL] [Abstract][Full Text] [Related]
59. Functional image-guided radiotherapy planning in respiratory-gated intensity-modulated radiotherapy for lung cancer patients with chronic obstructive pulmonary disease.
Kimura T; Nishibuchi I; Murakami Y; Kenjo M; Kaneyasu Y; Nagata Y
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e663-70. PubMed ID: 22245191
[TBL] [Abstract][Full Text] [Related]
60. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients.
Møller DS; Khalil AA; Knap MM; Muren LP; Hoffmann L
Acta Oncol; 2011 Aug; 50(6):883-8. PubMed ID: 21767188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
